🇺🇸
United States · US · US:76346-525_41bf3142-d0f6-4f0c-b6da-5abe8ad3db43
Lifyorli
Orange BookSPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerCorcept Therapeutics Incorporated
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1176346525031 BLISTER PACK in 1 CARTON (76346-525-03) / 1 KIT in 1 BLISTER PACK (76346-525-33) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-025-01) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-100-01)
- ndc1176346525093 CARTON in 1 CARTON (76346-525-09) / 1 BLISTER PACK in 1 CARTON (76346-525-03) / 1 KIT in 1 BLISTER PACK (76346-525-33) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-025-01) * 1 CAPSULE in 1 PACKAGE, COMBINATION (76346-100-01)
Annotations
Orange Book
N220641
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"route": "ORAL",
"spl_meta": {
"6fcebfb5-19d6-4f63-b852-999d68a13729": {
"match": "brand_token",
"title": "LIFYORLI (RELACORILANT) KIT [CORCEPT THERAPEUTICS INCORPORATED]",
"spl_version": "1",
"published_date": "2026-03-30"
}
},
"productid": "76346-525_41bf3142-d0f6-4f0c-b6da-5abe8ad3db43",
"productndc": "76346-525",
"dosage_form": "KIT",
"orange_book": {
"appl_no": "220641",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "100MG;25MG",
"product_no": "001",
"approval_date": "Mar 25, 2026"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": null,
"proprietary_name": "Lifyorli",
"active_ingred_unit": null,
"application_number": "NDA220641",
"marketing_category": "NDA",
"nonproprietary_name": "Relacorilant",
"start_marketing_date": "20260325",
"active_numerator_strength": null
}Access this data programmatically
Query Lifyorli and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.